“…Retrospective cohort studies maintained the indications for EO ( 13 , 14 , 17 ), showing that it is a safe procedure for large tumours (> 5 cm), multicentric tumours, and multifocal tumours with acceptable complication rates (7.7% to 28%) ( 8 , 9 , 13 , 14 , 17 ) and low recurrence rates at a follow-up of > 5 years (6% to 9%) ( 12 , 17 ). Some studies mentioned breast sized/tumour size ratio or resection size to breast size ratio ( 35 , 36 ), which can be used for small- and medium-sized breasts, using regional tissue transfer with local/regional flaps ( 18 , 35 – 37 ). We also observed new options, such as regional flaps ( 38 – 47 ), partial breast amputation ( 48 – 51 ), and flap guides for central tumours ( 52 ).…”